Structured evidence table for Boron Joint Pain Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Boron Joint Pain Randomized Trial | These interactions collectively promote the DFG-out conformation and enhance binding affinity and selectivity.Limitations of the drug: treatment may cause elevated Aspartate Aminotransferase (AST)/Alanine Aminotransferase (ALT) and fetal risk, so liver tests and contraception are advised. | 3 | Jadala Chetna (2026) | Nitrogen-containing FDA-approved drugs in 2025: synthesis, significance and therapeutic applications |
| Boron Joint Pain Randomized Trial | Dordaviprone received Orphan Drug, Rare Pediatric Disease, and Fast Track designations and was approved under accelerated approval based on response rate and duration of response, pending confirmatory evidence of clinical benefit. | 3 | Jadala Chetna (2026) | Nitrogen-containing FDA-approved drugs in 2025: synthesis, significance and therapeutic applications |
| Boron Joint Pain Randomized Trial | The fluoroaryl intermediate (79) is further elaborated through a Suzuki–Miyaura cross-coupling with [4-(trifluoromethyl)phenyl]boronic acid to generate the diaryl ketone (80), which is reduced with LiBHEtto the corresponding secondary alcohol (81). | 3 | Jadala Chetna (2026) | Nitrogen-containing FDA-approved drugs in 2025: synthesis, significance and therapeutic applications |
| Boron Joint Pain Randomized Trial | 1–3 4 5,6 7 8 9–12 Heterocyclic compounds, in general, constitute an important class of naturally occurring molecules with favorable physicochemical and biological properties, conferring substantial pharmaceutical relevance. | 3 | Jadala Chetna (2026) | Nitrogen-containing FDA-approved drugs in 2025: synthesis, significance and therapeutic applications |
| Boron Joint Pain Randomized Trial | SBEs occur naturally in commonly consumed herbs, vegetables, fruits, seeds, and nuts and, other than greatly varying levels of B found in local drinking water, are the primary natural dietary sources of B-containing molecules in humans. | 4 | Hunter JM (2018) | The Fructoborates: Part of a Family of Naturally Occurring Sugar-Borate Complexes-Biochemistry, Physiology, and Impact on Human Health: a Review. |
| Boron Joint Pain Randomized Trial | Potential health benefits of CaFB have been clinically investigated in pilot and efficacy studies demonstrating (i) significant reductions in knee discomfort and improved flexibility within 7, 14, and 90 days and (ii) significant effect on blood levels of inflammatory, cardiovascular, and other biomarkers. | 4 | Hunter JM (2018) | The Fructoborates: Part of a Family of Naturally Occurring Sugar-Borate Complexes-Biochemistry, Physiology, and Impact on Human Health: a Review. |
| Boron Joint Pain Randomized Trial | Considering recent National Health and Nutrition Examination Survey (NHANES) data reporting increases in age-related joint pain and an increasing elderly demographic, SBEs offer potential for safe, natural, and effective management of joint discomfort and improved mobility in human and animal health applications. | 4 | Hunter JM (2018) | The Fructoborates: Part of a Family of Naturally Occurring Sugar-Borate Complexes-Biochemistry, Physiology, and Impact on Human Health: a Review. |
| Boron Joint Pain Randomized Trial | Sugar-borates (SBs) are mono- or di-sugar-borate esters (SBEs) comprised of one or two monosaccharide molecules linked to a boron (B) atom. | 4 | Hunter JM (2018) | The Fructoborates: Part of a Family of Naturally Occurring Sugar-Borate Complexes-Biochemistry, Physiology, and Impact on Human Health: a Review. |
Source documents